Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research
Sponsored

Radiopharm Theranostics (ASX: RAD) to showcase innovations at B. Riley Securities Radiopharma Investor Conference - Kalkine Media

February 23, 2024 11:56 AM AEDT | By Team Kalkine Media
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
Radiopharm Theranostics (ASX: RAD) to showcase innovations at B. Riley Securities Radiopharma Investor Conference

Recent News

thumbnail

Petrobras: Analysts celebrate extra dividend, already expecting the ot...

thumbnail

Gold snaps five-week win streak, but bull run not over yet: MS

thumbnail

U.S. shares higher at close of trade; Dow Jones Industrial Average up...

thumbnail

Canada shares higher at close of trade; S&P/TSX Composite up 0.38%

Highlights

  • RAD has secured a spot at B. Riley Securities Event for radiopharmaceutical advancements.
  • The event will feature over 15 small-to-mid cap public and private companies from the CDMO, industrial, biotech, medtech, and medical services space.

Radiopharm Theranostics (ASX: RAD) is excited to announce its invitation to participate in the B. Riley Securities Radiopharma Investor Conference on 1 March 2024. This event is scheduled to take place in New York.

Over 15 public and private companies (small-to-mid cap) focused on introducing life-saving radiotherapeutics and imaging agents to the market will participate in the event. These companies are from the medtech, medical services, biotech, CDMO (contract development & manufacturing organization), and industrial space.   

During the conference, Radiopharm's management will deliver an exclusive presentation about the company, and they will also participate in a panel discussion addressing imaging in radiopharmaceuticals. This opportunity allows them to engage with various institutional and professional investors from the United States, providing valuable insights into the company's advancements and contributions to the field.

RAD is a clinical-stage biopharmaceutical company dedicated to advancing innovative radiopharmaceuticals in areas with significant medical needs.

RAD shares traded at AU$0.058 on 22 February 2024.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

5 ASX Companies Leveraging AI to Drive Growth in 2024



We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.